Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Pyxis Oncology, Inc. (PYXS) had Return on Equity of -74.43% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-23.27M |
|
-- |
|
-- |
|
$24.36M |
|
$-24.36M |
|
$1.09M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-23.27M |
|
$-24.36M |
|
$-24.14M |
|
63.47M |
|
63.47M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$45.57M |
|
$7.54M |
|
$18.73M |
|
$64.30M |
|
$16.53M |
|
-- |
|
$16.50M |
|
$33.03M |
|
$31.27M |
|
$31.27M |
|
$31.27M |
|
62.83M |
|
| Cash Flow Statement Financials | |
$-26.00M |
|
$16.37M |
|
$-0.03M |
|
$16.89M |
|
$7.24M |
|
$-9.66M |
|
$1.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-74.43% |
-74.43% |
|
-36.19% |
|
-74.43% |
|
$0.50 |
|
$-0.41 |
|
$-0.41 |
|